Diffuse Intrinsic Pontine Glioma (DIPG) is an aggressive pediatric brainstem tumor with limited treatment options and a poor prognosis. This article offers a comprehensive overview of DIPG’s diagnosis, symptoms, treatment options, and survival rates. It also discusses the importance of seeking second opinions and advanced care through platforms like Medebound HEALTH, highlighting the story of an Asian family who found new hope through virtual consultations with US specialists

This blog explores lung cancer survival rates across different stages and highlights how access to early diagnosis and advanced U.S. treatments—such as targeted therapies and immunotherapy—can significantly improve outcomes. It also explains how Medebound HEALTH supports international patients, especially from Asia, in consulting U.S. lung cancer experts and accessing clinical trials or travelling for care.

This blog explores liver cancer survival rates and highlights how Asian patients can benefit from advanced treatment options in the U.S. through Medebound HEALTH. From video consultations with top liver cancer experts to support for travelling abroad and applying for clinical trials, patients gain access to world-class care with ease.